Ablation Frontiers
2004
FOUNDED
M&A
STATUS
801-900
EMPLOYEES
M&A
LATEST DEAL TYPE
$225M
LATEST DEAL AMOUNT
Description
Developer and marketer of cardiac ablation devices for the treatment of individuals suffering from atrial fibrillation and other cardiac arrhythmia. The company offers mapping and ablation catheters, RF generators, and accessories. It markets its cardiac ablation systems in the European Union and other international markets.
Website
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Acquirer
Primary Office
- 2210 Faraday Avenue
- Suite 100
- Carlsbad, CA 92008
- United States
+1 (760) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Ablation Frontiers’s full profile, request a free trial.
Ablation Frontiers Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 12-Jan-2009 | $225M | 000.00 | 00000 | Completed | Generating Revenue |
| 3. Later Stage VC (Series C) | 09-Jul-2007 | 000.00 | 000.00 | Completed | Startup | |
| 2. Early Stage VC (Series B) | 23-Feb-2006 | $15.1M | $18.7M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 18-Jun-2004 | $3.6M | $3.6M | Completed | Startup |
Ablation Frontiers Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Aberdare Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Affinity Capital Management | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Hexagon (Denver) | PE/Buyout | Minority | 000 0000 | 000000 0 | ||
| Longitude Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Novartis Venture Fund | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |